Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 256 AL 270

Therapeutic targeting of microtubule affinity-regulating kinase 4 in cancer and neurodegenerative diseases

Alam M, Ahmed S, Abid M, Hasan GM, Islam A, Hassan MI.

J Cell Biochem. 2023 Sep;124(9):1223-1240. doi: 10.1002/jcb.30468. Epub 2023 Sep 3.

Berberine derivatives as inhibitors of acetylcholinesterase: A systematic review

Singh YP, Kumar H.

Chem Biol Drug Des. 2023 Dec;102(6):1592-1603. doi: 10.1111/cbdd.14337. Epub 2023 Sep 4.

Lithium: An Old Drug for New Therapeutic Strategy for Alzheimer's Disease and Related Dementia

Shim SS, Berglund K, Yu SP.

Neurodegener Dis. 2023;23(1-2):1-12. doi: 10.1159/000533797. Epub 2023 Sep 4.

Tryptamine: A privileged scaffold for the management of Alzheimer's disease

Singh YP, Kumar H.

Drug Dev Res. 2023 Dec;84(8):1578-1594. doi: 10.1002/ddr.22111. Epub 2023 Sep 7.

Guilingji capsule for Alzheimer's disease: secondary analysis of a randomized non-inferiority controlled trial

Ming Z, Yimiao L, Huichan W, Yu C, Lina MA, Hui P, Hao LI.

J Tradit Chin Med. 2023 Oct;43(5):1019-1025. doi: 10.19852/j.cnki.jtcm.20230404.006.

Pathogenesis of Alzheimer's Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential

Singh A, Singh K, Kaur J, Kaur R, Sharma A, Kaur J, Kaur U, Chadha R, Bedi PMS.

ACS Chem Neurosci. 2023 Sep 20;14(18):3291-3317. doi: 10.1021/acschemneuro.3c00393. Epub 2023 Sep 8.

Advances in Alzheimer's Disease-Associated Aβ Therapy Based on Peptide

Wang C, Shao S, Li N, Zhang Z, Zhang H, Liu B.

Int J Mol Sci. 2023 Aug 23;24(17):13110. doi: 10.3390/ijms241713110.

Carbamate as a potential anti-Alzheimer's pharmacophore: A review

Singh YP, Kumar N, Chauhan BS, Garg P.

Drug Dev Res. 2023 Dec;84(8):1624-1651. doi: 10.1002/ddr.22113. Epub 2023 Sep 11.

A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers

Sabbagh MN, Mathew P, Blau A.

Alzheimer Dis Assoc Disord. 2023 Oct-Dec 01;37(4):290-295. doi: 10.1097/WAD.0000000000000578. Epub 2023 Sep 11.

Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood

Bourdakou MM, Fernández-Ginés R, Cuadrado A, Spyrou GM.

Redox Biol. 2023 Nov;67:102881. doi: 10.1016/j.redox.2023.102881. Epub 2023 Sep 7.

Translational strategies and systems biology insights for blood-brain barrier opening and delivery in brain tumors and Alzheimer's disease

Song G, Plumlee P, Ahn JY, Wong ST, Zhao H.

Biomed Pharmacother. 2023 Nov;167:115450. doi: 10.1016/j.biopha.2023.115450. Epub 2023 Sep 11.

The neuroinflammatory astrocytic P2X7 receptor: Alzheimer's disease, ischemic brain injury, and epileptic state

Ahn YH, Tang Y, Illes P.

Expert Opin Ther Targets. 2023 Jul-Dec;27(9):763-778. doi: 10.1080/14728222.2023.2258281. Epub 2023 Sep 15.

Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer's Disease

Nakamura Y, Narita K, Kim R, Nishiyama K, Kikuchi T, Ishikawa I, Aoki H.

J Alzheimers Dis. 2023;95(4):1535-1543. doi: 10.3233/JAD-230386.

Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab

VandeVrede L, La Joie R, Horiki S, Mundada NS, Koestler M, Hwang JH, Ljubenkov PA, Rojas JC, Rabinovici GD, Boxer AL, Seeley WW.

Acta Neuropathol. 2023 Nov;146(5):777-781. doi: 10.1007/s00401-023-02631-8. Epub 2023 Sep 19.

Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer's Disease: Recent Trends and Future Development

Dave BP, Shah YB, Maheshwari KG, Mansuri KA, Prajapati BS, Postwala HI, Chorawala MR.

Cell Mol Neurobiol. 2023 Nov;43(8):3847-3884. doi: 10.1007/s10571-023-01408-7. Epub 2023 Sep 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias